summary
Introduced
10/14/2025
10/14/2025
In Committee
10/15/2025
10/15/2025
Crossed Over
Passed
Dead
Introduced Session
104th General Assembly
Bill Summary
Amends the Pharmacy Practice Act. Provides that the Department of Financial and Professional Regulation shall authorize the examination of applicants as pharmacists at such times and places as it may determine (rather than not less than 3 times per year). Provides that the Department and the Board of Pharmacy shall regularly monitor the North American Pharmacist Licensure Examination or its successor to ensure that the examination of applicants is of a character to give a fair test of the qualifications of the applicant to practice pharmacy. Provides that applicants for examination as pharmacists for the calendar years 2025, 2026, and 2027 shall be required to pass only the North American Pharmacist Licensure Examination. Provides that the results from the Multistate Pharmacy Jurisprudence Examination for such applicants shall be disregarded and shall not prohibit an applicant who has successfully passed the North American Pharmacist Licensure Examination from engaging in the practice of pharmacy. Provides that applicants for examination as pharmacists shall be required to pay, either to the Department or the National Association of Boards of Pharmacy (rather than the designated testing service), a fee covering the cost of providing the examination. Provides that the Department shall notify applicants taking the examination of their results no later than 2 weeks after (rather than within 7 weeks of) the examination date. Makes conforming changes.
AI Summary
This bill amends the Pharmacy Practice Act to modify the licensing and examination process for pharmacists in Illinois. The key changes include giving the Department of Financial and Professional Regulation more flexibility in scheduling pharmacist examinations, removing the requirement to conduct exams at least three times per year. For calendar years 2025-2027, applicants will only need to pass the North American Pharmacist Licensure Examination (NAPLEX), with the Multistate Pharmacy Jurisprudence Examination (MPJE) results being disregarded. Applicants can now pay the examination fee directly to the Department or the National Association of Boards of Pharmacy, instead of a designated testing service. The Department must now notify applicants of their examination results within 2 weeks (shortened from 7 weeks), and applicants who successfully pass the exam will be immediately authorized to practice pharmacy. The bill maintains existing requirements for foreign pharmacy graduates, including obtaining an FPGEC Certificate, completing 1,200 hours of clinical training in the United States, and meeting other licensing requirements. These changes aim to streamline the pharmacist licensing process and provide more efficient examination and notification procedures.
Sponsors (2)
Last Action
Added Chief Co-Sponsor Rep. Ryan Spain (on 02/26/2026)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...